Phase 4Completed
A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia
A Multicenter Clinical Trial to Compare the Efficacy and Safety Between Rosuvastatin/Ezetimibe Combination and Monotherapy of Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia
- Sponsor
- Yuhan Corporation (Industry)
- Enrollment
- 85 enrolled
- Conditions
- Diabetes Mellitus and Hypercholesterolemia
- Interventions
- Rosuvastatin+Ezetimibe; Rosuvastatin
- Ages
- adults, older adults
- Registry
- NCT03217409
Full record on ClinicalTrials.gov
From the registry
A Study to Compare Rosuvastatin/Ezetimibe Combination and Monotherapy in Patients with Diabetes Mellitus and Hypercholesterolemia.
Primary outcomes
- Low density lipoprotein cholesterol (LDL-C) (%)
History
Last registry update
Study completion
Primary completion
Started
Registered